abstract |
Disclosed herein are cannabinoid re-ceptor ligands of formula (I) wherein L1, A1, R1g, z, R2, R3, and R4 are as defined in the specification. Compositions comprising such compounds and meth-ods for treating conditions and disorders using such compounds and compositions are also presented. |